Opening subject page...
Loading your content
Understanding the spectrum of myocardial ischemia from unstable angina to STEMI for rapid prehospital recognition and intervention.
The understanding of acute coronary syndromes (ACS) has evolved dramatically over the past century, transforming from a poorly understood cause of sudden death into a well-characterized spectrum of disease with defined prehospital treatment protocols. Before modern cardiology, myocardial infarction was largely a post-mortem diagnosis, and chest pain was often attributed to vague constitutional ailments. The recognition that coronary artery occlusion produces myocardial necrosis was itself a paradigm shift, and the subsequent development of electrocardiography, cardiac biomarkers, and percutaneous coronary intervention has revolutionized both in-hospital and prehospital management. For paramedics, this history is not merely academic—every protocol you follow in the field traces its lineage to key discoveries that redefined how we identify and treat ischemic heart disease in its most acute presentations.
The central question driving the modern prehospital approach to ACS is this: how can a paramedic rapidly differentiate between the subtypes of ACS in the field, initiate time-sensitive treatments, and minimize the interval from symptom onset to definitive reperfusion therapy? Every minute of delay in restoring coronary blood flow translates to additional myocardial tissue loss, encapsulated in the axiom "time is muscle." This lesson will equip you with the pathophysiological foundation, ECG recognition skills, and treatment algorithms necessary to manage ACS effectively at the paramedic level.
Acute coronary syndromes represent a continuum of myocardial ischemia caused by an acute reduction in coronary blood flow, almost always resulting from the rupture or erosion of an atherosclerotic plaque with subsequent thrombus formation. The spectrum ranges from unstable angina (UA), in which ischemia occurs without detectable myocardial necrosis, through non-ST-elevation myocardial infarction (NSTEMI), where partial occlusion causes some necrosis, to ST-elevation myocardial infarction (STEMI), where complete occlusion produces transmural ischemia and injury. Understanding the pathophysiological basis for each entity allows the paramedic to anticipate complications, interpret 12-lead findings accurately, and select appropriate interventions.
The diagram above emphasizes the critical relationship between the degree of coronary occlusion and the clinical presentation. In unstable angina, the thrombus is labile and may partially occlude the vessel, producing transient ischemia without sufficient duration or severity to cause detectable necrosis—hence cardiac troponin levels remain within the normal reference range. As the thrombus burden increases or collateral circulation proves insufficient, subendocardial myocytes begin to die, producing the elevated troponin that distinguishes NSTEMI from UA. The ECG in NSTEMI typically shows ST depression or deep T-wave inversion, reflecting subendocardial injury patterns. When the thrombus completely and persistently occludes the coronary artery, the full thickness of the myocardial wall served by that vessel becomes ischemic and then injured, producing the hallmark ST elevation that defines STEMI and demands emergent reperfusion therapy.
The heart receives its blood supply from the left main coronary artery (which bifurcates into the left anterior descending and left circumflex arteries) and the right coronary artery. The left anterior descending (LAD) artery supplies the anterior wall and the interventricular septum; occlusion here produces anterior STEMI with ST elevation in leads V₁ through V₄. The left circumflex (LCx) artery supplies the lateral wall, reflected in leads I, aVL, V₅, and V₆. The right coronary artery (RCA) supplies the inferior wall and, in most patients, the posterior descending artery—inferior STEMI manifests in leads II, III, and aVF. Understanding these territories is essential for paramedics performing prehospital 12-lead ECG interpretation, as the pattern of ST elevation localizes the culprit vessel and predicts specific complications.
Following complete coronary occlusion, myocardial necrosis begins in the subendocardium—the innermost layer of the ventricular wall, which is most vulnerable to ischemia because it experiences the highest wall stress and has the most tenuous blood supply. Over the ensuing 4 to 6 hours, the zone of necrosis expands outward in a wavefront pattern toward the epicardium. The rate of wavefront progression depends on the presence or absence of collateral circulation, the metabolic demands of the tissue, and any residual antegrade flow through the occluded vessel. This concept is the pathophysiological basis for the time-dependent benefit of reperfusion therapy: the sooner flow is restored, the more myocardium is salvaged from irreversible necrosis.
At the cellular level, ischemia halts oxidative phosphorylation within seconds, forcing the myocyte to rely on anaerobic glycolysis. Intracellular ATP levels fall, lactate accumulates, and the cell becomes acidotic. The sodium-potassium ATPase pump fails, leading to intracellular sodium and calcium overload. Membrane potential becomes unstable—this is the mechanistic basis for the malignant ventricular dysrhythmias (ventricular tachycardia and ventricular fibrillation) that are the leading cause of prehospital death in acute MI. Ultimately, if ischemia persists, the cell membrane ruptures, releasing intracellular contents—including cardiac troponin I or T—into the bloodstream, providing the biochemical marker of myocardial necrosis.
The 12-lead ECG is the single most important diagnostic tool available to the paramedic for differentiating ACS subtypes. Accurate interpretation requires understanding contiguous lead groups (leads that view the same anatomical region of the heart), the criteria for ST elevation, and the significance of reciprocal changes (ST depression in leads opposite the area of injury, which increases the specificity of STEMI diagnosis). The paramedic must also recognize STEMI equivalents, including new left bundle branch block (LBBB), posterior MI patterns, and de Winter T-waves, which may not show classic ST elevation but require the same emergent management.
| ACS Type | ECG Findings | Troponin | Thrombus Character |
|---|---|---|---|
| Unstable Angina | Normal, transient ST depression, or T-wave inversion; may be dynamic | Negative (below 99th percentile URL) | White (platelet-rich), non-occlusive or transiently occlusive |
| NSTEMI | ST depression ≥ 0.5 mm, deep T-wave inversion, or transient ST elevation; no persistent ST elevation | Positive (above 99th percentile URL with rise/fall pattern) | Mixed (platelet + fibrin), subtotal occlusion with intermittent distal embolization |
| STEMI | Persistent ST elevation in ≥ 2 contiguous leads meeting voltage criteria; reciprocal depression; may evolve to Q waves | Markedly positive (peaks 12–24 h post-onset) | Red (fibrin-rich), complete and persistent occlusion |
The following scenario walks through a systematic approach to a patient presenting with suspected ACS in the prehospital setting. This example integrates history taking, ECG interpretation, pharmacological intervention, and transport decision-making.
Prehospital management of ACS involves a combination of pharmacological therapies and transport decisions, each with distinct advantages and limitations. The choice between fibrinolytic therapy and primary percutaneous coronary intervention (PCI) for STEMI remains one of the most consequential decisions in emergency cardiovascular care, and paramedics must understand the factors that guide this choice in systems where both options are available.
| Intervention | Strengths | Limitations |
|---|---|---|
| Aspirin (antiplatelet) | Reduces mortality by approximately 23% in acute MI (ISIS-2 trial). Rapid onset when chewed. Available in all EMS systems. Few absolute contraindications. | Does not dissolve existing thrombus. Risk of GI bleeding. Contraindicated in true aspirin allergy or active GI hemorrhage. |
| Nitroglycerin | Reduces preload and myocardial oxygen demand. Provides symptomatic relief. May be diagnostic—chest pain of ischemic origin often improves with NTG. | Contraindicated in hypotension (SBP < 90), right ventricular infarction, recent PDE-5 inhibitor use. Does not improve mortality. Reflex tachycardia possible. |
| Fibrinolytic therapy | Can be administered in the field. Most beneficial within 0–3 hours of symptom onset. Critical when PCI is unavailable or transport time exceeds 120 minutes. | Risk of hemorrhagic stroke (0.5–1%). Multiple absolute contraindications. Achieves TIMI 3 flow in only ~50–60% of patients. Less effective than PCI overall. |
| Primary PCI | Gold standard for STEMI reperfusion. Achieves TIMI 3 flow in >90% of cases. Lower risk of hemorrhagic stroke. Allows definitive anatomic assessment. | Requires cath lab with experienced team. Benefit diminishes as FMC-to-balloon time exceeds 120 minutes. Not universally available in rural areas. |
| Heparin (anticoagulation) | Prevents thrombus propagation and reocclusion. Synergistic with fibrinolytics. Standard component of STEMI treatment bundles. | Requires weight-based dosing. Risk of bleeding. Does not lyse existing clot. Requires monitoring (not feasible prehospital). HIT is rare but serious. |
The prehospital management of ACS connects directly to advanced in-hospital concepts including risk stratification scoring, interventional cardiology techniques, and post-resuscitation care for patients who experience cardiac arrest secondary to ACS. A strong paramedic-level foundation in ACS pathophysiology makes these advanced topics more intuitive and ensures seamless continuity of care during patient handoff. Understanding the broader trajectory of care also helps paramedics anticipate the information that emergency physicians and interventional cardiologists need to make rapid decisions.
| Paramedic-Level Concept | Advanced In-Hospital Extension |
|---|---|
| Prehospital 12-lead ECG interpretation for STEMI identification | Coronary angiography confirms culprit lesion; FFR (fractional flow reserve) quantifies hemodynamic significance of non-culprit stenoses |
| Troponin as a marker of myocardial necrosis (binary positive/negative in field) | High-sensitivity troponin assays with serial measurements enable 0/1-hour and 0/3-hour rapid rule-out/rule-in algorithms for NSTEMI |
| Heparin and aspirin for anticoagulation/antiplatelet therapy | Dual antiplatelet therapy (DAPT) with P2Y₁₂ inhibitors (clopidogrel, ticagrelor, prasugrel) plus glycoprotein IIb/IIIa inhibitors in the cath lab |
| Symptomatic NTG for demand reduction | IV nitroglycerin infusions, intra-aortic balloon pump (IABP), and Impella devices for hemodynamic support in cardiogenic shock |
| Defibrillation for VF/pulseless VT arrest complicating ACS | Targeted temperature management (TTM), emergent cardiac catheterization for OHCA survivors, and left ventricular assist devices for refractory cardiogenic shock |
Acute coronary syndromes represent a spectrum of myocardial ischemia caused by atherosclerotic plaque rupture and intracoronary thrombus formation. The spectrum ranges from unstable angina (ischemia without necrosis; troponin-negative) to NSTEMI (partial occlusion with detectable necrosis; troponin-positive, no persistent ST elevation) to STEMI (complete occlusion with transmural injury; ST elevation in contiguous leads meeting voltage criteria). Myocardial necrosis progresses in a wavefront pattern from subendocardium to epicardium over 4–6 hours, making early reperfusion essential—time is muscle.
The paramedic's role centers on rapid recognition through 12-lead ECG interpretation, identification of coronary artery territories (LAD → anterior; LCx → lateral; RCA → inferior), and initiation of evidence-based pharmacotherapy including aspirin, nitroglycerin (with contraindication awareness for RV infarct and hypotension), and heparin. For STEMI, the transport decision between a PCI-capable center (preferred if FMC-to-balloon ≤ 120 min) and fibrinolytic-capable facility (when PCI access is delayed) is among the most consequential clinical judgments a paramedic makes. Atypical presentations—especially in women, diabetics, and the elderly—demand a high index of suspicion and serial ECG monitoring.